Barely Significant
← all excerpts

Clinical validation of an immunohistochemistry-based CanAssist-Breast test for distant recurrence prediction in hormone receptor-positive breast cancer patients.

Cancer Med · 2019 · PMC6488210 · PMID 30848103

Europe PMCDOI
1
hedged sentence
0.0001
closest p · 0.0× alpha
0.0001
boldest claim

The sentences

highly significantP ‐value of <0.0001actually significant
When the same cohort was stratified by CAB, the results showed a higher difference in DMFS (10.84%) between the low‐ and high‐risk categories with a highly significant P ‐value of <0.0001 (Figure 2 A) suggesting that CAB is a better prognostic predictor in comparison to node status.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.